Stephen Baxter
Stock Analyst at Wells Fargo
(3.60)
# 2,186
Out of 5,010 analysts
715
Total ratings
49%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Rated: Hold | $27 | $29.77 | -9.30% | 33 | Sep 16, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $307 | $275.26 | +11.53% | 41 | Sep 15, 2026 | |
| CNC Centene | Reiterated: Hold | $69 | $62.21 | +10.91% | 52 | Sep 15, 2026 | |
| CVS CVS Health | Reiterated: Buy | $123 | $87.10 | +41.22% | 53 | Sep 15, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $473 | $392.73 | +20.44% | 50 | Sep 15, 2026 | |
| HUM Humana | Reiterated: Buy | $502 | $386.87 | +29.76% | 62 | Sep 15, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $220 | $189.38 | +16.17% | 56 | Sep 15, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $526 | $374.94 | +40.29% | 53 | Sep 15, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $277 | $223.91 | +23.71% | 23 | Sep 9, 2026 | |
| UHS Universal Health Services | Reiterated: Hold | $166 | $175.73 | -5.54% | 36 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.26 | +85.19% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 → $40 | $35.34 | +13.19% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $331 → $395 | $307.60 | +28.41% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $812 → $933 | $864.82 | +7.88% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 → $34 | $34.98 | -2.80% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $141 → $146 | $78.15 | +86.82% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $46 | $40.50 | +13.58% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 | $55.69 | +40.06% | 23 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $369 → $381 | $431.63 | -11.73% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $231 → $281 | $257.60 | +9.08% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $2.91 | -31.27% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $5.75 | +39.13% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $40 | $13.14 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $308.81 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $622.11 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $231.97 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $295.96 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $268.99 | n/a | 1 | Nov 14, 2019 |
Oscar Health
Sep 16, 2026
Rated: Hold
Price Target: $27
Current: $29.77
Upside: -9.30%
The Cigna Group
Sep 15, 2026
Reiterated: Hold
Price Target: $307
Current: $275.26
Upside: +11.53%
Centene
Sep 15, 2026
Reiterated: Hold
Price Target: $69
Current: $62.21
Upside: +10.91%
CVS Health
Sep 15, 2026
Reiterated: Buy
Price Target: $123
Current: $87.10
Upside: +41.22%
Elevance Health
Sep 15, 2026
Reiterated: Buy
Price Target: $473
Current: $392.73
Upside: +20.44%
Humana
Sep 15, 2026
Reiterated: Buy
Price Target: $502
Current: $386.87
Upside: +29.76%
Molina Healthcare
Sep 15, 2026
Reiterated: Hold
Price Target: $220
Current: $189.38
Upside: +16.17%
UnitedHealth Group
Sep 15, 2026
Reiterated: Buy
Price Target: $526
Current: $374.94
Upside: +40.29%
Cardinal Health
Sep 9, 2026
Reiterated: Buy
Price Target: $277
Current: $223.91
Upside: +23.71%
Universal Health Services
Sep 8, 2026
Reiterated: Hold
Price Target: $166
Current: $175.73
Upside: -5.54%
Aug 14, 2026
Reiterated: Buy
Price Target: $19
Current: $10.26
Upside: +85.19%
Aug 11, 2026
Rated: Buy
Price Target: $28 → $40
Current: $35.34
Upside: +13.19%
Aug 11, 2026
Rated: Buy
Price Target: $331 → $395
Current: $307.60
Upside: +28.41%
Aug 11, 2026
Rated: Hold
Price Target: $812 → $933
Current: $864.82
Upside: +7.88%
Aug 11, 2026
Rated: Hold
Price Target: $47 → $34
Current: $34.98
Upside: -2.80%
Aug 10, 2026
Reiterated: Buy
Price Target: $141 → $146
Current: $78.15
Upside: +86.82%
Aug 10, 2026
Rated: Buy
Price Target: $45 → $46
Current: $40.50
Upside: +13.58%
Aug 3, 2026
Reiterated: Buy
Price Target: $78
Current: $55.69
Upside: +40.06%
Aug 3, 2026
Rated: Hold
Price Target: $369 → $381
Current: $431.63
Upside: -11.73%
Jul 31, 2026
Rated: Buy
Price Target: $231 → $281
Current: $257.60
Upside: +9.08%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $2.91
Upside: -31.27%
Oct 29, 2025
Reiterated: Hold
Price Target: $8
Current: $5.75
Upside: +39.13%
May 1, 2024
Reiterated: Hold
Price Target: $4 → $40
Current: $13.14
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $308.81
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $622.11
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $231.97
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $295.96
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $268.99
Upside: n/a